GPER1 as a therapeutic target in MASLD: evidence for steatosis attenuation by agonist G1 in preclinical models.

Front Pharmacol · 2026 · PMC13038608 · PMID 41929249

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, the enrichment significance (FDR >0.05) for these pathways did not reach statistical significance ( Supplementary Figures S5, S6 ). 4.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.